SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,938 | +52.0% | 19,704 | +77.0% | 0.01% | -16.7% |
| Q2 2023 | $1,275 | -16.9% | 11,135 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $1,535 | +6.4% | 11,135 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,443 | -99.9% | 11,135 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $1,231,000 | +47.4% | 11,135 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $835,000 | -4.0% | 11,135 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $870,000 | -13.3% | 11,135 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,003,000 | -2.6% | 11,135 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $1,030,000 | +18.9% | 11,135 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $866,000 | +4.3% | 11,135 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $830,000 | -56.3% | 11,135 | 0.0% | 0.00% | -55.6% |
| Q4 2020 | $1,898,000 | +21.4% | 11,135 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $1,564,000 | -12.4% | 11,135 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $1,785,000 | +63.9% | 11,135 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $1,089,000 | -20.0% | 11,135 | +5.6% | 0.01% | 0.0% |
| Q4 2019 | $1,361,000 | +71.4% | 10,545 | 0.0% | 0.01% | +60.0% |
| Q3 2019 | $794,000 | -50.4% | 10,545 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $1,602,000 | +27.4% | 10,545 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $1,257,000 | -11.2% | 10,545 | -18.7% | 0.01% | -20.0% |
| Q4 2018 | $1,415,000 | -31.9% | 12,966 | +0.8% | 0.01% | -23.1% |
| Q3 2018 | $2,077,000 | +22.4% | 12,861 | +0.2% | 0.01% | +18.2% |
| Q2 2018 | $1,697,000 | +117.3% | 12,840 | +21.8% | 0.01% | +120.0% |
| Q1 2018 | $781,000 | +33.0% | 10,545 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $587,000 | +22.8% | 10,545 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $478,000 | +34.6% | 10,545 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $355,000 | +13.8% | 10,545 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $312,000 | +8.0% | 10,545 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $289,000 | -55.4% | 10,545 | 0.0% | 0.00% | -60.0% |
| Q3 2016 | $648,000 | +175.7% | 10,545 | -14.5% | 0.01% | +150.0% |
| Q2 2016 | $235,000 | -3.3% | 12,338 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $243,000 | -46.5% | 12,462 | +5.9% | 0.00% | -50.0% |
| Q4 2015 | $454,000 | +121.5% | 11,768 | +84.4% | 0.00% | +100.0% |
| Q3 2015 | $205,000 | +5.7% | 6,383 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $194,000 | – | 6,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |